First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status

First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status:



Publication date: May 2020

Source: European Journal of Cancer, Volume 130

Author(s): Francesco Facchinetti, Giulia Mazzaschi, Fausto Barbieri, Francesco Passiglia, Francesca Mazzoni, Rossana Berardi, Claudia Proto, Fabiana Letizia Cecere, Sara Pilotto, Vieri Scotti, Sabrina Rossi, Alessandro Del Conte, Emanuele Vita, Chiara Bennati, Andrea Ardizzoni, Giulio Cerea, Maria Rita Migliorino, Elisa Sala, Andrea Camerini, Alessandra Bearz